Photo-Bombing Cancer
November 21, 2016
Drugs for hepatitis C and diabetes drove Medicare spending in 2015
November 22, 2016
Show all

Mental illness no barrier to treating hepatitis C

Hepatitis C treatments are safe to use in the mentally ill population.

A recent study found that sofosbuvir-based therapy is safe to treat patients with hepatitis C virus (HCV) who also have mental health disease (MHD), and that there may even be benefits, although it is unclear how long the benefits may last. The study was published in the World Journal of Hepatology as an article in press on September 8, 2016, and was conducted by Lydia Shuk Yee Tang, MD, of the Institute of Human Virology in the Division of Infectious Diseases at the University of Maryland School of Medicine, and colleagues.

The aim of the study, say the authors, was “to study impact of baseline mental health disease on hepatitis C virus treatment; and Beck’s Depression Inventory (BDI) changes with sofosbuvir- and interferon-based therapy.” In order to investigate, the researchers conducted a retrospective cohort study, and examined the data collected on participants in 5 other studies. Those participants all had some form of MHD, including major depression, bipolar disorder, schizophrenia, generalized anxiety, post-traumatic stress disorder, or a prescription of antidepressants, antipsychotics, mood stabilizers, or psychotropics.

The researchers report, “Sofosbuvir-based therapy was equally effective among participants with MHD, and among those without MHD.” Additionally, patients with MHD showed similar levels of adherence and had similar sustained virologic response (SVR) as those without MHD.

“Furthermore, among participants with HIV/HCV coinfection treated with DAA therapy, we observed a statistically significant improvement in BDI scores during and after the end of treatment point (post-treatment) compared to baseline (pre-treatment), while participants treated with IFN-based therapy saw no significant change in BDI scores,” say the researchers.

Read Full Article: Mental illness no barrier to treating hepatitis C | EATG

Read Full Article: Mental illness no barrier to treating hepatitis C | EATG

The health and medical information on our website is not intended to take the place of advice or treatment from health care professionals. It is also not intended to substitute for the users’ relationships with their own health care/pharmaceutical providers.

Comments are closed.